maleimide has been researched along with chondroitin sulfates in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellamkonda, RV; García, AJ; Gutowski, SM; LaPlaca, MC; Latour, RA; Shoemaker, JT; Templeman, KL; Wei, Y | 1 |
| Cho, HJ; Kang, NW; Kim, DD; Kim, DH; Kim, S; Lee, HS; Lee, JY; Lee, SY; Yoon, IS | 1 |
2 other study(ies) available for maleimide and chondroitin sulfates
| Article | Year |
|---|---|
Protease-degradable PEG-maleimide coating with on-demand release of IL-1Ra to improve tissue response to neural electrodes.
Topics: Amino Acid Sequence; Animals; Astrocytes; Blood-Brain Barrier; Cell Adhesion; Cell Survival; Cells, Cultured; Chondroitin Sulfates; Coated Materials, Biocompatible; Electrodes, Implanted; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Hydrogel, Polyethylene Glycol Dimethacrylate; Immunoglobulin G; Inflammation Mediators; Interleukin 1 Receptor Antagonist Protein; Lipopolysaccharides; Male; Maleimides; Microglia; Molecular Sequence Data; Neurons; Peptide Hydrolases; Polyethylene Glycols; Rats, Sprague-Dawley; Surface Properties | 2015 |
Blood component ridable and CD44 receptor targetable nanoparticles based on a maleimide-functionalized chondroitin sulfate derivative.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Chondroitin Sulfates; Drug Carriers; Drug Liberation; Female; Humans; Hyaluronan Receptors; Maleimides; MCF-7 Cells; Nanoparticles; Particle Size; Polyethylene Glycols; Rats | 2020 |